Doxorubicin-loaded composite nanogels for cancer treatment

J Control Release. 2020 Dec 10:328:171-191. doi: 10.1016/j.jconrel.2020.08.033. Epub 2020 Aug 28.

Abstract

Nanogels as a versatile vehicle for doxorubicin have attracted great attention during the last decade. Since a nanogel composite device transport encapsulated drugs to the site of action and release them in a desirable time-frame, it could provide higher therapeutic effect. By implementation of different polymers, polymer/inorganic NPs and various crosslinking chemistry, it is possible to fabricate novel composite nanogel systems with favorable characteristics such as smart intelligent systems or multipurpose platforms. Due to high stability, good drug loading capacity for hydrophobic and hydrophilic agents, nanogels introduce great opportunity in pharmaceutical innovations. Composite nanogels show capability in gene, drug and diagnostic agents' delivery while providing an ideal platform for theranostic purposes as multifunctional systems. Doxorubicin as an anticancer agent is widely used against numerous cancers. Due to high systemic toxicity of doxorubicin, there is still need for its safe and specific delivery to the site of action. In this regard, so many efforts have been put in by the researchers for preparation of different nanogel formulations of doxorubicin in order to produce more efficient formulations. This review focuses on design, fabrication, advantages and disadvantages of composite nanogel-based doxorubicin formulations.

Keywords: Composite; Doxorubicin; Drug delivery; Nanogel; Polymer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents*
  • Doxorubicin
  • Drug Carriers
  • Drug Delivery Systems
  • Hydrophobic and Hydrophilic Interactions
  • Nanogels
  • Neoplasms* / drug therapy
  • Polyethylene Glycols
  • Polymers

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Nanogels
  • Polymers
  • Polyethylene Glycols
  • Doxorubicin